UK Co-codamol Shortage Until June 2026
Analysis based on 9 articles · First reported Jan 29, 2026 · Last updated Feb 13, 2026
The co-codamol shortage in the United Kingdom negatively impacts the pharmaceutical and healthcare sectors, potentially leading to increased demand for alternative painkillers and putting pressure on the United Kingdom===National Health Service. This event highlights vulnerabilities in the medicine supply chain, which could affect investor confidence in related industries.
The United Kingdom is experiencing a severe national shortage of co-codamol, a painkiller relied upon by millions. The shortage primarily affects 30mg/500mg tablets and is expected to last until at least June 2026. The National Pharmacy Association has reported that pharmacies are struggling to obtain supplies and are assisting 'distressed patients.' NHS trusts, including United Kingdom===NHS Grampian, have confirmed the issue and are advising patients on alternative pain relief options like paracetamol. The United Kingdom===Department of Health and Social Care has added co-codamol to a list of medicines that cannot be hoarded or exported from the United Kingdom and has issued guidance to healthcare professionals not to initiate new patients on the drug. Olivier Picard, Chair of the National Pharmacy Association, has called for urgent government action to address the growing list of medicine shortages and improve the medicine supply system.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard